Indiana Hemophilia and Thrombosis Center

The Indiana Hemophilia and Thrombosis Center (IHTC) is a leading federally recognized Hemophilia Treatment Center (HTC) and a center of excellence for the treatment of rare blood disorders. Based in Indianapolis, IHTC provides comprehensive clinical care, including diagnostic testing, pharmacy services, and multidisciplinary support for patients with hemophilia, sickle cell disease, and clotting disorders. Beyond patient care, IHTC is a prolific clinical research site, participating in numerous international clinical trials for novel therapeutics, including gene therapies and long-acting factor replacements. The center is recognized for its integrated model of care and its significant contributions to hematology research and education. It operates as a non-profit organization dedicated to improving patient outcomes through both direct service and scientific advancement.